3151
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Vital KSK Holdings is a Japanese pharmaceutical distribution and healthcare services group operating through five business segments. The company manages pharmaceutical wholesale, pharmacy operations, veterinary pharmaceutical distribution, pharmaceutical manufacturing, and care rental and other services. Key subsidiaries include Vital Net, KSK, Fines, Ono, Good Neighbor, Kenkoudou Pharmacy, Tennohoken Pharmacy Center, Agro Japan, Arrow Medical, Medly Pharma, and Tampo. The group serves customers in the healthcare sector, including hospitals, pharmacies, and veterinary clinics, while also providing logistics, insurance agency, real estate management, and consulting services.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Medical Distribution Homepage vitalksk.co.jp
Sector Healthcare IR page vitalksk.co.jp
Tags
pharmaceutical wholesale, pharmacy operations, veterinary pharmaceuticals, pharmaceutical manufacturing, care rental, logistics, insurance agency, real estate management, consulting services, Vital Net, KSK, Fines, Ono, Good Neighbor, Kenkoudou Pharmacy, Tennohoken Pharmacy Center, Agro Japan, Arrow Medical, Medly Pharma, Tampo, Yachiyo Care Support, Medical Management Research Institute, Vital Green, Vital Care, Vital Express, Oshin Trading, Preark, Kyowa Transport
Press page vitalksk.co.jp/ir/news

Metrics

Valuation  
Market cap ¥ 80.294B
Market cap (USD) $ 501.843M
P/E 26.18
PEG 1.74
P/BV 0.69
P/S 0.13
P/OCF 37.21
P/FCF -19.55
Dividend yield 4.5%
Turnover / mcap —
Returns  
ROE 6.5%
ROI 6.0%
ROIC 2.1%
Profit margin 1.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 15.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 24
Quality score 5.6%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 610.497B 600.37B 587.481B 579.772B 577.249B 537.03B 562.505B 559.712B 565.589B 581.079B 621.04B 548.012B 564.655B 547.581B
Net profit 7.362B 7.308B 5.843B 4.831B 4.77B 1.171B 4.642B 5.084B 4.467B 4.778B 6.556B 4.527B 4.235B 3.908B
Free cash flow -435M -10.587B 18.472B -8.841B 3.347B -5.234B -9.834B 16.089B 8.55B -3.793B -6.579B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 1.465K 1.258K 1.256K 894.33 735.03 789.04 1.097K 1.092K 1.047K 1.032K 887.73 915.05 778.94 872.04
Price performance 12m 0.16 0 0.4 0.22 -0.07 -0.28 0 0.04 0.01 0.16 -0.03 0.17 -0.11 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 126B 122B 122B 115B 115B 239B 237B 236B 234B 242B
↳ YoY growth -15.1% -3.0% +0.1% -5.8% -0.4% +108.6% -1.0% -0.3% -0.9% +3.7%
↳ 5y CAGR -5.0% +13.7% +14.2% +14.1% +15.2% +16.2%
Other receivables (JPY) 15.1B 15.4B 15.3B 15.1B 15.4B 16.6B 16.7B 16.3B 12B 12.8B
Borrowings, current (JPY) 3.59B 1.36B 1.37B 1.6B 6.57B 1.96B 1.96B 1.86B 1.87B 1.93B
Borrowings, non-current (JPY) 14.8B 14.8B 14.8B 14.4B 8.73B 7.76B 6.79B 5.82B 4.85B 3.89B
Bonds payable (JPY) 10B 10B 10B 10B — — — — — —
Lease liabilities (JPY) 1.04B 869M 1.96B 1.61B 1.5B 2.13B 1.5B 1.43B 979M 952M
Cash and deposits (JPY) 23B 28.3B 43.2B 33.1B 29.8B 27B 19B 34.7B 23.1B 23B
Intangible assets (JPY) 7.42B 6.74B 5.79B 5.04B 4.59B 5.04B 3.38B 3.91B 4.29B 6.89B
Net debt (borrowings + leases - cash) (JPY) -3.55B -11.2B -25.1B -15.5B -13B -15.1B -8.78B -25.6B -15.4B -16.2B
Cash flow detail
Operating cash flow (JPY) 1.12B 16.8B 18.2B -8.32B -1.39B 7.49B -3B 23.6B -8.02B 4.83B
Purchases of property, plant and equipment (JPY) -4.48B -7.83B -1.61B -1.15B -3.31B -3.42B -5.84B -1.85B -2.56B -3.72B
Purchases of intangible assets (JPY) -432M -408M -533M -361M -533M -725M -759M -3.25B -1.77B -1.55B
Change in receivables (cash effect) (JPY) 23.9B 3.43B 77M 7.22B 494M -6.04B 1.07B 824M 5.5B -4.88B
Change in inventories (cash effect) (JPY) 1.2B -401M -1.21B -165M 1.65B -2.45B 942M -552M -1.8B -3M
Change in payables (cash effect) (JPY) -26.4B 7.16B 11.7B -21.3B -1.63B 9.62B -12.1B 14.5B -16.9B 7.24B
Dividends paid (cash effect) (JPY) -1.46B -1.13B -1.13B -1.29B -1.38B -651M -1.37B -2.37B -2.18B -2.81B
Share buybacks (cash effect) (JPY) -135M 0.00 0.00 -1.5B 0.00 -1.56B -998M -1.63B -2.51B 0.00
Interest paid (cash effect) (JPY) -45M -45M -73M -66M -88M -98M -96M -103M -80M -68M
Income taxes paid (cash effect) (JPY) -4.85B -662M -2.23B -2.84B -2.86B -1.51B -3.53B -3.56B -2.92B -2.96B
Operating cash flow before change in receivables (JPY) -22.8B 13.4B 18.2B -15.5B -1.88B 13.5B -4.07B 22.7B -13.5B 9.71B
Free cash flow (OCF - PPE - intangibles) (JPY) -3.79B 8.55B 16.1B -9.83B -5.23B 3.35B -9.6B 18.5B -12.4B -435M
Income detail
Research and development expense (JPY) — — — — — — — — — 1.28B
Total comprehensive income (JPY) 6.21B 9.57B -527M 3.2B 7.67B -1.66B 2.49B 9.76B 5.93B 14.1B
Comprehensive income to owners (JPY) 6.12B 9.49B -615M 3.1B 7.55B -1.77B 2.39B 9.66B 5.84B 14B
Provision for credit losses (JPY) — — — — — -15M 568M -336M 49M 23M
Credit cost ratio (credit losses / average receivables) (%) — — — — — 0.0% 0.2% 0.1% 0.0% 0.0%
Segments
Medicine Wholesale · Segment revenue (JPY) — — — — — — — — 575B 584B
↳ YoY growth +1.5%
Medicine Wholesale · Segment operating income (JPY) — — — — — — — — 5.16B 4.92B
Nursing Care Related Rental And Other Business · Segment revenue (JPY) — — — — — — — — 7.32B 7.87B
↳ YoY growth +7.5%
Nursing Care Related Rental And Other Business · Segment operating income (JPY) — — — — — — — — -78M -102M
Pharmaceutical Business · Segment operating income (JPY) — — — — — — — — — -1.31B
Pharmacy Business · Segment revenue (JPY) — — — — 16.8B 18.4B 18.4B 19.1B 19.6B 20B
↳ YoY growth +9.7% -0.2% +4.1% +2.3% +2.1%
Pharmacy Business · Segment operating income (JPY) — — — — -19M 205M 106M 310M 251M 252M
Veterinary Drugs Wholesale Business · Segment revenue (JPY) — — — 9.71B 9.81B 10.4B 10.9B 11B 11.6B 12.6B
↳ YoY growth +1.0% +6.0% +4.6% +1.4% +5.4% +8.6%
Veterinary Drugs Wholesale Business · Segment operating income (JPY) — — — 353M 401M 371M 339M 350M 314M 304M
Reported Jun 30, 2017 Jun 29, 2018 Jun 28, 2019 Jun 28, 2021 Jun 29, 2022 Jun 30, 2023 Jun 30, 2023 Jun 27, 2024 Jun 19, 2026 Jun 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Vital KSK Holdings, Inc. (ticker 3151), listed in Japan.

ETFs Holding Vital KSK Holdings, Inc.

ETF Weight in ETF Shares Market value As of
DISV 0.03% 188,400 $ 1.658M Nov 12, 2026
DFIS 0.01% 66,700 $ 586.91K Nov 12, 2026
AVDV 0.01% 245,500 $ 2.207M Nov 16, 2026
AVSD 0.01% 2,400 $ 21.576K Nov 16, 2026
AVDS 0.01% 5,800 $ 52.142K Nov 16, 2026
DXIV 0.01% 1,800 $ 15.839K Nov 12, 2026
DFSI 0.00% 5,500 $ 48.396K Nov 12, 2026
DFIC 0.00% 43,522 $ 382.961K Nov 12, 2026
DFAX 0.00% 27,400 $ 241.099K Nov 12, 2026
DFAI 0.00% 28,400 $ 249.899K Nov 12, 2026
AVDE 0.00% 67,700 $ 608.621K Nov 16, 2026